News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Endologix Inc. Reports 22% First Quarter 2010 Revenue Growth
April 23, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
IRVINE, Calif., April 22 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq:ELGX - News), developer of minimally invasive treatments for aortic disorders, today announced financial results for the three months ended March 31, 2010.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Earnings
Moderna Misses Q1 Revenue Expectations, Plans Another $1.5B in Cuts
May 1, 2025
·
3 min read
·
Annalee Armstrong
Earnings
Lilly’s Revenue Leaps 45% Thanks to Zepbound, Mounjaro, Of Course
May 1, 2025
·
1 min read
·
Annalee Armstrong
Deals
Novartis Strikes on M&A, Leading a Line of Big Pharmas With Cash to Spend
April 30, 2025
·
5 min read
·
Annalee Armstrong
Layoffs
Entrada Cuts 20% of Workforce, Targeting Research Employees
April 30, 2025
·
1 min read
·
Angela Gabriel
